nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—PTGS1—malignant glioma	0.767	1	CbGaD
Montelukast—CYP3A4—Temozolomide—malignant glioma	0.0283	1	CbGbCtD
Montelukast—Traumatic liver injury—Temozolomide—malignant glioma	0.00496	0.0538	CcSEcCtD
Montelukast—Otitis media—Temozolomide—malignant glioma	0.00237	0.0258	CcSEcCtD
Montelukast—Memory impairment—Temozolomide—malignant glioma	0.00235	0.0256	CcSEcCtD
Montelukast—Liver injury—Temozolomide—malignant glioma	0.0022	0.0238	CcSEcCtD
Montelukast—Disturbance in attention—Temozolomide—malignant glioma	0.00213	0.0232	CcSEcCtD
Montelukast—Viral infection—Temozolomide—malignant glioma	0.00205	0.0222	CcSEcCtD
Montelukast—Neuropathy—Carmustine—malignant glioma	0.0018	0.0195	CcSEcCtD
Montelukast—Neuropathy—Temozolomide—malignant glioma	0.00173	0.0188	CcSEcCtD
Montelukast—Ear pain—Temozolomide—malignant glioma	0.00157	0.0171	CcSEcCtD
Montelukast—Gastroenteritis—Temozolomide—malignant glioma	0.00151	0.0164	CcSEcCtD
Montelukast—Injury—Carmustine—malignant glioma	0.00151	0.0164	CcSEcCtD
Montelukast—Thirst—Temozolomide—malignant glioma	0.00141	0.0153	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00121	0.0131	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00121	0.0131	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00118	0.0128	CcSEcCtD
Montelukast—Bronchitis—Temozolomide—malignant glioma	0.00111	0.0121	CcSEcCtD
Montelukast—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00108	0.0117	CcSEcCtD
Montelukast—Pneumonia—Carmustine—malignant glioma	0.00108	0.0117	CcSEcCtD
Montelukast—Neuropathy peripheral—Carmustine—malignant glioma	0.00105	0.0114	CcSEcCtD
Montelukast—Pneumonia—Temozolomide—malignant glioma	0.00104	0.0113	CcSEcCtD
Montelukast—Infestation NOS—Temozolomide—malignant glioma	0.00103	0.0112	CcSEcCtD
Montelukast—Infestation—Temozolomide—malignant glioma	0.00103	0.0112	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00102	0.0111	CcSEcCtD
Montelukast—Neuropathy peripheral—Temozolomide—malignant glioma	0.00101	0.011	CcSEcCtD
Montelukast—Hepatobiliary disease—Temozolomide—malignant glioma	0.000977	0.0106	CcSEcCtD
Montelukast—Sinusitis—Temozolomide—malignant glioma	0.00097	0.0105	CcSEcCtD
Montelukast—Hallucination—Carmustine—malignant glioma	0.000955	0.0104	CcSEcCtD
Montelukast—Hypoaesthesia—Carmustine—malignant glioma	0.000955	0.0104	CcSEcCtD
Montelukast—Connective tissue disorder—Carmustine—malignant glioma	0.000943	0.0102	CcSEcCtD
Montelukast—Hepatitis—Temozolomide—malignant glioma	0.000928	0.0101	CcSEcCtD
Montelukast—Hypoaesthesia—Temozolomide—malignant glioma	0.000923	0.01	CcSEcCtD
Montelukast—Hallucination—Temozolomide—malignant glioma	0.000923	0.01	CcSEcCtD
Montelukast—Pharyngitis—Temozolomide—malignant glioma	0.000921	0.01	CcSEcCtD
Montelukast—Urinary tract disorder—Temozolomide—malignant glioma	0.000916	0.00995	CcSEcCtD
Montelukast—Connective tissue disorder—Temozolomide—malignant glioma	0.000912	0.0099	CcSEcCtD
Montelukast—Urethral disorder—Temozolomide—malignant glioma	0.00091	0.00987	CcSEcCtD
Montelukast—Erythema multiforme—Temozolomide—malignant glioma	0.000877	0.00952	CcSEcCtD
Montelukast—Cardiac disorder—Temozolomide—malignant glioma	0.000861	0.00935	CcSEcCtD
Montelukast—Mental disorder—Carmustine—malignant glioma	0.000841	0.00913	CcSEcCtD
Montelukast—Immune system disorder—Temozolomide—malignant glioma	0.000838	0.0091	CcSEcCtD
Montelukast—Mediastinal disorder—Temozolomide—malignant glioma	0.000836	0.00908	CcSEcCtD
Montelukast—Mental disorder—Temozolomide—malignant glioma	0.000813	0.00882	CcSEcCtD
Montelukast—Tremor—Carmustine—malignant glioma	0.000783	0.0085	CcSEcCtD
Montelukast—Agitation—Carmustine—malignant glioma	0.000768	0.00834	CcSEcCtD
Montelukast—Tremor—Temozolomide—malignant glioma	0.000757	0.00822	CcSEcCtD
Montelukast—Agitation—Temozolomide—malignant glioma	0.000742	0.00806	CcSEcCtD
Montelukast—Angioedema—Temozolomide—malignant glioma	0.000738	0.00801	CcSEcCtD
Montelukast—Convulsion—Carmustine—malignant glioma	0.000724	0.00786	CcSEcCtD
Montelukast—Palpitations—Temozolomide—malignant glioma	0.000714	0.00775	CcSEcCtD
Montelukast—Myalgia—Carmustine—malignant glioma	0.000712	0.00773	CcSEcCtD
Montelukast—Anxiety—Carmustine—malignant glioma	0.000709	0.0077	CcSEcCtD
Montelukast—Cough—Temozolomide—malignant glioma	0.000705	0.00765	CcSEcCtD
Montelukast—Convulsion—Temozolomide—malignant glioma	0.0007	0.0076	CcSEcCtD
Montelukast—Arthralgia—Temozolomide—malignant glioma	0.000688	0.00747	CcSEcCtD
Montelukast—Myalgia—Temozolomide—malignant glioma	0.000688	0.00747	CcSEcCtD
Montelukast—Anxiety—Temozolomide—malignant glioma	0.000685	0.00744	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000683	0.00741	CcSEcCtD
Montelukast—Oedema—Carmustine—malignant glioma	0.000682	0.00741	CcSEcCtD
Montelukast—Infection—Carmustine—malignant glioma	0.000678	0.00736	CcSEcCtD
Montelukast—Thrombocytopenia—Carmustine—malignant glioma	0.000668	0.00725	CcSEcCtD
Montelukast—Oedema—Temozolomide—malignant glioma	0.000659	0.00716	CcSEcCtD
Montelukast—Anaphylactic shock—Temozolomide—malignant glioma	0.000659	0.00716	CcSEcCtD
Montelukast—Infection—Temozolomide—malignant glioma	0.000655	0.00711	CcSEcCtD
Montelukast—Nervous system disorder—Temozolomide—malignant glioma	0.000646	0.00702	CcSEcCtD
Montelukast—Thrombocytopenia—Temozolomide—malignant glioma	0.000645	0.00701	CcSEcCtD
Montelukast—Skin disorder—Temozolomide—malignant glioma	0.00064	0.00695	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000621	0.00675	CcSEcCtD
Montelukast—Insomnia—Carmustine—malignant glioma	0.000617	0.0067	CcSEcCtD
Montelukast—Paraesthesia—Carmustine—malignant glioma	0.000613	0.00665	CcSEcCtD
Montelukast—Somnolence—Carmustine—malignant glioma	0.000606	0.00658	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000601	0.00652	CcSEcCtD
Montelukast—Insomnia—Temozolomide—malignant glioma	0.000596	0.00647	CcSEcCtD
Montelukast—Paraesthesia—Temozolomide—malignant glioma	0.000592	0.00643	CcSEcCtD
Montelukast—Gastrointestinal disorder—Carmustine—malignant glioma	0.000589	0.00639	CcSEcCtD
Montelukast—Somnolence—Temozolomide—malignant glioma	0.000586	0.00636	CcSEcCtD
Montelukast—Pain—Carmustine—malignant glioma	0.000583	0.00633	CcSEcCtD
Montelukast—Dyspepsia—Temozolomide—malignant glioma	0.00058	0.0063	CcSEcCtD
Montelukast—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000569	0.00618	CcSEcCtD
Montelukast—Fatigue—Temozolomide—malignant glioma	0.000568	0.00617	CcSEcCtD
Montelukast—Pain—Temozolomide—malignant glioma	0.000564	0.00612	CcSEcCtD
Montelukast—Gastrointestinal pain—Carmustine—malignant glioma	0.000558	0.00606	CcSEcCtD
Montelukast—Abdominal pain—Carmustine—malignant glioma	0.000539	0.00585	CcSEcCtD
Montelukast—Body temperature increased—Carmustine—malignant glioma	0.000539	0.00585	CcSEcCtD
Montelukast—Gastrointestinal pain—Temozolomide—malignant glioma	0.000539	0.00585	CcSEcCtD
Montelukast—Urticaria—Temozolomide—malignant glioma	0.000524	0.00569	CcSEcCtD
Montelukast—Abdominal pain—Temozolomide—malignant glioma	0.000521	0.00566	CcSEcCtD
Montelukast—Body temperature increased—Temozolomide—malignant glioma	0.000521	0.00566	CcSEcCtD
Montelukast—Hypersensitivity—Carmustine—malignant glioma	0.000503	0.00546	CcSEcCtD
Montelukast—Asthenia—Carmustine—malignant glioma	0.000489	0.00531	CcSEcCtD
Montelukast—Hypersensitivity—Temozolomide—malignant glioma	0.000486	0.00527	CcSEcCtD
Montelukast—Asthenia—Temozolomide—malignant glioma	0.000473	0.00513	CcSEcCtD
Montelukast—Diarrhoea—Carmustine—malignant glioma	0.000467	0.00507	CcSEcCtD
Montelukast—Pruritus—Temozolomide—malignant glioma	0.000466	0.00506	CcSEcCtD
Montelukast—Dizziness—Carmustine—malignant glioma	0.000451	0.0049	CcSEcCtD
Montelukast—Diarrhoea—Temozolomide—malignant glioma	0.000451	0.0049	CcSEcCtD
Montelukast—Dizziness—Temozolomide—malignant glioma	0.000436	0.00473	CcSEcCtD
Montelukast—Vomiting—Carmustine—malignant glioma	0.000434	0.00471	CcSEcCtD
Montelukast—Rash—Carmustine—malignant glioma	0.00043	0.00467	CcSEcCtD
Montelukast—Dermatitis—Carmustine—malignant glioma	0.00043	0.00466	CcSEcCtD
Montelukast—Headache—Carmustine—malignant glioma	0.000427	0.00464	CcSEcCtD
Montelukast—Vomiting—Temozolomide—malignant glioma	0.000419	0.00455	CcSEcCtD
Montelukast—Rash—Temozolomide—malignant glioma	0.000416	0.00451	CcSEcCtD
Montelukast—Dermatitis—Temozolomide—malignant glioma	0.000415	0.00451	CcSEcCtD
Montelukast—Headache—Temozolomide—malignant glioma	0.000413	0.00448	CcSEcCtD
Montelukast—Nausea—Carmustine—malignant glioma	0.000405	0.0044	CcSEcCtD
Montelukast—Nausea—Temozolomide—malignant glioma	0.000392	0.00425	CcSEcCtD
Montelukast—ALOX5—Metabolism—PTGS1—malignant glioma	8.1e-05	0.000718	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—RTEL1—malignant glioma	8.07e-05	0.000715	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.07e-05	0.000715	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—FBXW7—malignant glioma	7.99e-05	0.000708	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—GSTP1—malignant glioma	7.99e-05	0.000708	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	7.88e-05	0.000698	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—BDKRB2—malignant glioma	7.84e-05	0.000694	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—F2—malignant glioma	7.8e-05	0.000691	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—GSTT1—malignant glioma	7.6e-05	0.000673	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—BCHE—malignant glioma	7.53e-05	0.000667	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—AKT2—malignant glioma	7.52e-05	0.000667	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ASMT—malignant glioma	7.5e-05	0.000665	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CG—malignant glioma	7.47e-05	0.000662	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—SLC5A5—malignant glioma	7.44e-05	0.000659	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PTPN11—malignant glioma	7.33e-05	0.00065	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	7.33e-05	0.00065	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NOTCH2—malignant glioma	7.29e-05	0.000646	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—PIK3CD—malignant glioma	7.23e-05	0.00064	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KNG1—malignant glioma	7.13e-05	0.000632	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—PTGS1—malignant glioma	7.12e-05	0.000631	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ASMT—malignant glioma	7.09e-05	0.000629	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.09e-05	0.000628	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—BCAN—malignant glioma	7.05e-05	0.000625	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.03e-05	0.000623	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.97e-05	0.000618	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.86e-05	0.000608	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—AKT2—malignant glioma	6.83e-05	0.000605	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NTRK1—malignant glioma	6.8e-05	0.000602	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—BCAN—malignant glioma	6.67e-05	0.000591	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CD—malignant glioma	6.56e-05	0.000582	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.36e-05	0.000564	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MMP3—malignant glioma	6.32e-05	0.00056	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—PIK3CB—malignant glioma	6.3e-05	0.000558	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CDKN2B—malignant glioma	6.26e-05	0.000555	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTK2—malignant glioma	6.08e-05	0.000539	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.08e-05	0.000539	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—CXCL8—malignant glioma	6.05e-05	0.000536	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GSTP1—malignant glioma	5.99e-05	0.000531	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HES1—malignant glioma	5.97e-05	0.000529	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NCOR1—malignant glioma	5.94e-05	0.000526	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—RAF1—malignant glioma	5.86e-05	0.000519	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CAT—malignant glioma	5.83e-05	0.000517	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—IL2—malignant glioma	5.79e-05	0.000513	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.77e-05	0.000511	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CB—malignant glioma	5.72e-05	0.000507	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—COX8A—malignant glioma	5.7e-05	0.000505	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PDGFRA—malignant glioma	5.69e-05	0.000504	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—IDH2—malignant glioma	5.68e-05	0.000504	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	5.58e-05	0.000495	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SPP1—malignant glioma	5.52e-05	0.000489	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—NCOR1—malignant glioma	5.51e-05	0.000488	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CXCL8—malignant glioma	5.5e-05	0.000487	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—IDH2—malignant glioma	5.38e-05	0.000476	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.36e-05	0.000475	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP2B6—malignant glioma	5.34e-05	0.000474	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—RTEL1—malignant glioma	5.32e-05	0.000472	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—GSTP1—malignant glioma	5.27e-05	0.000467	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL2—malignant glioma	5.25e-05	0.000466	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TERT—malignant glioma	5.23e-05	0.000464	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	5.19e-05	0.00046	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PDGFB—malignant glioma	5.11e-05	0.000453	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.09e-05	0.000451	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—FGFR1—malignant glioma	5.08e-05	0.00045	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP2B6—malignant glioma	5.05e-05	0.000448	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HIF1A—malignant glioma	5.01e-05	0.000444	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—IDH1—malignant glioma	4.89e-05	0.000433	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ASMT—malignant glioma	4.84e-05	0.000429	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CAV1—malignant glioma	4.84e-05	0.000429	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KDR—malignant glioma	4.79e-05	0.000424	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.74e-05	0.00042	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SPHK1—malignant glioma	4.73e-05	0.000419	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—COX8A—malignant glioma	4.64e-05	0.000411	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP2C18—malignant glioma	4.63e-05	0.000411	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—IDH1—malignant glioma	4.62e-05	0.00041	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—FN1—malignant glioma	4.61e-05	0.000408	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—F2—malignant glioma	4.61e-05	0.000408	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—BCAN—malignant glioma	4.56e-05	0.000404	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—BAD—malignant glioma	4.55e-05	0.000404	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NOTCH1—malignant glioma	4.51e-05	0.0004	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CAV1—malignant glioma	4.49e-05	0.000398	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SPHK1—malignant glioma	4.47e-05	0.000396	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CD80—malignant glioma	4.42e-05	0.000392	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—APC—malignant glioma	4.41e-05	0.000391	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CG—malignant glioma	4.41e-05	0.000391	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP2C18—malignant glioma	4.38e-05	0.000388	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.37e-05	0.000387	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EGF—malignant glioma	4.36e-05	0.000386	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTPN11—malignant glioma	4.33e-05	0.000384	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.29e-05	0.00038	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.15e-05	0.000367	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—BRAF—malignant glioma	4.15e-05	0.000367	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CG—malignant glioma	4.09e-05	0.000362	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AKT2—malignant glioma	4.04e-05	0.000358	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—EGFR—malignant glioma	4.02e-05	0.000356	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.98e-05	0.000353	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PPARG—malignant glioma	3.95e-05	0.00035	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ASMT—malignant glioma	3.94e-05	0.000349	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CD—malignant glioma	3.88e-05	0.000344	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.85e-05	0.000342	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.84e-05	0.00034	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—PIK3CA—malignant glioma	3.84e-05	0.00034	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—KRAS—malignant glioma	3.8e-05	0.000336	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTT1—malignant glioma	3.75e-05	0.000332	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—FGF2—malignant glioma	3.71e-05	0.000329	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—BCAN—malignant glioma	3.71e-05	0.000329	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—IDH2—malignant glioma	3.67e-05	0.000325	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CD—malignant glioma	3.59e-05	0.000318	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTT1—malignant glioma	3.54e-05	0.000314	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.5e-05	0.00031	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CA—malignant glioma	3.49e-05	0.000309	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MDM2—malignant glioma	3.47e-05	0.000308	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.46e-05	0.000307	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—RAF1—malignant glioma	3.46e-05	0.000307	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP2B6—malignant glioma	3.45e-05	0.000306	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ERBB2—malignant glioma	3.42e-05	0.000303	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CB—malignant glioma	3.38e-05	0.000299	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS1—malignant glioma	3.32e-05	0.000294	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—BCHE—malignant glioma	3.26e-05	0.000289	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CXCL8—malignant glioma	3.25e-05	0.000288	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SLC5A5—malignant glioma	3.22e-05	0.000286	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—IDH1—malignant glioma	3.16e-05	0.00028	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—AKT1—malignant glioma	3.14e-05	0.000278	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CB—malignant glioma	3.13e-05	0.000278	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CASP3—malignant glioma	3.11e-05	0.000275	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTGS2—malignant glioma	3.1e-05	0.000275	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL2—malignant glioma	3.1e-05	0.000275	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—BCHE—malignant glioma	3.09e-05	0.000274	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—COX8A—malignant glioma	3.06e-05	0.000271	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SPHK1—malignant glioma	3.06e-05	0.000271	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.05e-05	0.00027	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SLC5A5—malignant glioma	3.05e-05	0.00027	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.02e-05	0.000268	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP2C18—malignant glioma	2.99e-05	0.000265	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—IDH2—malignant glioma	2.99e-05	0.000265	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MMP9—malignant glioma	2.94e-05	0.00026	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTEN—malignant glioma	2.92e-05	0.000259	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—AKT1—malignant glioma	2.85e-05	0.000252	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.82e-05	0.00025	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.82e-05	0.00025	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.81e-05	0.000249	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTEN—malignant glioma	2.71e-05	0.00024	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—VEGFA—malignant glioma	2.64e-05	0.000234	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.64e-05	0.000234	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—STAT3—malignant glioma	2.61e-05	0.000231	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ASMT—malignant glioma	2.6e-05	0.00023	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTP1—malignant glioma	2.6e-05	0.00023	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.57e-05	0.000228	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—IDH1—malignant glioma	2.57e-05	0.000228	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CAT—malignant glioma	2.53e-05	0.000224	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SPHK1—malignant glioma	2.49e-05	0.00022	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.48e-05	0.00022	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTP1—malignant glioma	2.46e-05	0.000218	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—BCAN—malignant glioma	2.44e-05	0.000217	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP2C18—malignant glioma	2.44e-05	0.000216	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MYC—malignant glioma	2.43e-05	0.000215	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTT1—malignant glioma	2.42e-05	0.000215	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CAT—malignant glioma	2.39e-05	0.000212	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NCOR1—malignant glioma	2.39e-05	0.000212	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EGFR—malignant glioma	2.37e-05	0.00021	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.3e-05	0.000204	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS1—malignant glioma	2.27e-05	0.000201	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.26e-05	0.0002	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NCOR1—malignant glioma	2.26e-05	0.0002	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KRAS—malignant glioma	2.24e-05	0.000199	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—BCHE—malignant glioma	2.11e-05	0.000187	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.09e-05	0.000185	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC5A5—malignant glioma	2.08e-05	0.000185	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CA—malignant glioma	2.06e-05	0.000183	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.02e-05	0.000179	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TP53—malignant glioma	1.99e-05	0.000177	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—IDH2—malignant glioma	1.97e-05	0.000175	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTT1—malignant glioma	1.97e-05	0.000175	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.97e-05	0.000175	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.95e-05	0.000173	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CAV1—malignant glioma	1.95e-05	0.000172	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CA—malignant glioma	1.91e-05	0.000169	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.86e-05	0.000165	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.85e-05	0.000164	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS1—malignant glioma	1.85e-05	0.000164	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CAV1—malignant glioma	1.84e-05	0.000163	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.84e-05	0.000163	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CG—malignant glioma	1.77e-05	0.000157	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—BCHE—malignant glioma	1.72e-05	0.000152	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARG—malignant glioma	1.71e-05	0.000152	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.7e-05	0.000151	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.7e-05	0.00015	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—IDH1—malignant glioma	1.69e-05	0.00015	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AKT1—malignant glioma	1.68e-05	0.000149	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTP1—malignant glioma	1.68e-05	0.000149	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CG—malignant glioma	1.68e-05	0.000149	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SPHK1—malignant glioma	1.64e-05	0.000145	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CAT—malignant glioma	1.63e-05	0.000145	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARG—malignant glioma	1.62e-05	0.000143	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.61e-05	0.000142	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.6e-05	0.000142	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.59e-05	0.000141	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AKT1—malignant glioma	1.56e-05	0.000138	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CD—malignant glioma	1.56e-05	0.000138	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NCOR1—malignant glioma	1.54e-05	0.000137	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CD—malignant glioma	1.47e-05	0.000131	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.39e-05	0.000123	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTP1—malignant glioma	1.37e-05	0.000121	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CB—malignant glioma	1.36e-05	0.00012	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTGS2—malignant glioma	1.35e-05	0.000119	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CAT—malignant glioma	1.33e-05	0.000118	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTT1—malignant glioma	1.3e-05	0.000115	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CB—malignant glioma	1.28e-05	0.000114	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS2—malignant glioma	1.27e-05	0.000113	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CAV1—malignant glioma	1.26e-05	0.000111	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NCOR1—malignant glioma	1.25e-05	0.000111	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS1—malignant glioma	1.22e-05	0.000108	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.2e-05	0.000106	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTEN—malignant glioma	1.17e-05	0.000104	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.14e-05	0.000101	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—BCHE—malignant glioma	1.13e-05	0.0001	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.12e-05	9.91e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTEN—malignant glioma	1.11e-05	9.83e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARG—malignant glioma	1.11e-05	9.79e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CAV1—malignant glioma	1.02e-05	9.07e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CD—malignant glioma	1.01e-05	8.92e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.77e-06	8.66e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CG—malignant glioma	9.32e-06	8.26e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTP1—malignant glioma	9.01e-06	7.98e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARG—malignant glioma	8.99e-06	7.97e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CB—malignant glioma	8.77e-06	7.77e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CAT—malignant glioma	8.76e-06	7.77e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS2—malignant glioma	8.69e-06	7.7e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CA—malignant glioma	8.28e-06	7.34e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NCOR1—malignant glioma	8.28e-06	7.33e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CD—malignant glioma	8.19e-06	7.26e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CA—malignant glioma	7.83e-06	6.94e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTEN—malignant glioma	7.58e-06	6.72e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CB—malignant glioma	7.14e-06	6.33e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS2—malignant glioma	7.07e-06	6.27e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKT1—malignant glioma	6.76e-06	5.99e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CAV1—malignant glioma	6.75e-06	5.98e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKT1—malignant glioma	6.4e-06	5.67e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTEN—malignant glioma	6.17e-06	5.47e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CG—malignant glioma	6.15e-06	5.45e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARG—malignant glioma	5.93e-06	5.26e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CD—malignant glioma	5.4e-06	4.79e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CA—malignant glioma	5.35e-06	4.74e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.71e-06	4.17e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS2—malignant glioma	4.67e-06	4.13e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKT1—malignant glioma	4.37e-06	3.87e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CA—malignant glioma	4.35e-06	3.86e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTEN—malignant glioma	4.07e-06	3.61e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKT1—malignant glioma	3.56e-06	3.15e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.87e-06	2.54e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKT1—malignant glioma	2.35e-06	2.08e-05	CbGpPWpGaD
